2010
DOI: 10.1007/s11845-010-0527-x
|View full text |Cite
|
Sign up to set email alerts
|

Secondary prevention for coronary artery disease: are we following the guidelines?

Abstract: Our audit shows that targets for prescription of secondary prevention medications were not met in a small but significant proportion of patients and calls for review of discharge practices and education to improve compliance with guidelines.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
0
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
2
0
0
Order By: Relevance
“…Almost all eligible patients were prescribed aspirin at arrival and discharge and most patients received dual antiplatelet therapy. These findings are similar to many other studies from around the world . Aspirin plays an essential role in ACS treatment .…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Almost all eligible patients were prescribed aspirin at arrival and discharge and most patients received dual antiplatelet therapy. These findings are similar to many other studies from around the world . Aspirin plays an essential role in ACS treatment .…”
Section: Discussionsupporting
confidence: 92%
“…Prescribing beta blockers should be, therefore, improved focusing on female patients and patients with heart failure or STEMI. Finally, we observed higher rates of using ACEI/ARBs and statins than previous studies . This is encouraging as recommendations in guidelines are based on several trials supporting the role of ACEI/ARBs (ISIS‐4, GISSI‐3 trials, etc.)…”
Section: Discussionsupporting
confidence: 72%